Sensorion SA (EPA:ALSEN)
France · Delayed Price · Currency is EUR 0.4180
-0.0070 (-1.65%)
Apr 2, 2026, 5:35 PM CET
Sensorion Revenue
In the year 2025, Sensorion had annual revenue of 5.81M EUR, down -12.61%. Sensorion had revenue of 3.49M in the half year ending December 31, 2025, with 10.91% growth.
Revenue
5.81M
Revenue Growth
-12.61%
P/S Ratio
37.01
Revenue / Employee
92.29K
Employees
63
Market Cap
215.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.81M | -839.00K | -12.61% |
| Dec 31, 2024 | 6.65M | 955.00K | 16.76% |
| Dec 31, 2023 | 5.70M | 764.35K | 15.49% |
| Dec 31, 2022 | 4.93M | 669.94K | 15.71% |
| Dec 31, 2021 | 4.26M | 1.91M | 81.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 174.66M |
| Cellectis | 67.79M |
| Genfit | 45.13M |
| MedinCell | 32.44M |
| Adocia | 12.88M |
| Innate Pharma | 9.01M |
| Transgene | 7.21M |
| MaaT Pharma | 4.52M |